JPH02255082A - Transformant having tryptophanase productivity and production of l-tryptophan - Google Patents

Transformant having tryptophanase productivity and production of l-tryptophan

Info

Publication number
JPH02255082A
JPH02255082A JP1077874A JP7787489A JPH02255082A JP H02255082 A JPH02255082 A JP H02255082A JP 1077874 A JP1077874 A JP 1077874A JP 7787489 A JP7787489 A JP 7787489A JP H02255082 A JPH02255082 A JP H02255082A
Authority
JP
Japan
Prior art keywords
tryptophan
production
transformant
plasmid
tryptophanase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1077874A
Other languages
Japanese (ja)
Other versions
JP2754689B2 (en
Inventor
Makoto Shirai
真 白井
Kyosuke Yomoto
四本 喬介
Yoshizumi Ueda
植田 吉純
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Priority to JP1077874A priority Critical patent/JP2754689B2/en
Publication of JPH02255082A publication Critical patent/JPH02255082A/en
Application granted granted Critical
Publication of JP2754689B2 publication Critical patent/JP2754689B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/52Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

PURPOSE:To obtain the subject transformant of a bacterium belonging to Providencia genus producing an enzyme capable of converting pyruvic acid or L-serine to L-tryptophan in a high efficiency by carrying out transformation using a DNA containing a gene controlling tryptophanase production. CONSTITUTION:A gene controlling tryptophanase production is subjected to self-cloning using P.rettgeri plasmid to form a complex plasmid having the gene controlling tryptophanase production. Using the resultant complex plasmid, a bacterium belonging to Providencia genus is transformed.

Description

【発明の詳細な説明】 〈産業上の利用分野〉 本発明はトリフトファナーゼの生産を司る遺伝子を含む
組換え体DNAを有する形質転換体および、その形質転
換体を用いてトリフトファナーゼ反応によりL−トリプ
トファンを製造する方法に関する。
Detailed Description of the Invention <Industrial Application Field> The present invention provides a transformant having a recombinant DNA containing a gene governing the production of tritifphanase, and a transformant for producing tritiftophanase using the transformant. The present invention relates to a method for producing L-tryptophan by reaction.

〈従来の技術〉 L−)リプトファンの生産方法としては、ブレビバクテ
リウム属、コリネバクテリウム属、バチルス属、エシェ
リキア属の菌株を用いた直接発酵法、およびエシェリキ
ア属、プロビデンシア属(旧プロテウス属)などの菌株
を用いた酵素法による生産が知られている。酵素法によ
るL−トリプトファンの製造法としては、プロビデンシ
ア・レットゲリ(旧プロテウス・レットゲリ、以下P、
 rettgeriと略す)のトリフトファナーゼ(E
C4,1,99,1)(文献1)を用いた方法がすぐれ
た方法として知られる。
<Prior art> L-)Lyptophan can be produced by direct fermentation using strains of the genus Brevibacterium, Corynebacterium, Bacillus, and Escherichia; ) is known to be produced by enzymatic methods using bacterial strains such as As a method for producing L-tryptophan using an enzymatic method, Providencia rettgeri (formerly Proteus rettgeri, hereafter P,
triftphanase (E
A method using C4,1,99,1) (Reference 1) is known as an excellent method.

〈発明が解決しようとする課題〉 このトリフトファナーゼを生産するために遺伝子操作を
適用すれはトリフトファナーゼの生産性の向上が期待さ
れ、さらにL−トリプトファン生産性の向上が期待され
る。
<Problem to be solved by the invention> Applying genetic manipulation to produce this tryptophanase is expected to improve the productivity of tryptophanase, and further improve the productivity of L-tryptophan. .

本発明者らは、かかる状況に鑑み創意工夫を成し、P、
 rettgeriの1ラスミドを用いて、トリフトフ
ァナーゼ生産を司る遺伝子をセルフクローニングし、ト
リフトファナーゼ生産を司る遺伝子を有する複合プラス
ミドを作製し、この複合プラスミドでプロビデンシア属
の菌を形質転換し、この形質転換体を用いて、トリフト
ファナーゼを生産させ、さらにトリフトファナーゼ反応
によりL−トリプトファン生産性を向上させることに成
功し、かくして本発明を完成させるに至った。
In view of this situation, the present inventors have made ingenuity, and P.
Using the 1 lasmid of E. rettgeri, self-cloning the gene governing tritifphanase production to create a composite plasmid having the gene governing tritifphanase production, and transforming Providencia bacteria with this composite plasmid, Using this transformant, we succeeded in producing tritifphanase and in improving L-tryptophan productivity through the tritiftophanase reaction, thus completing the present invention.

く課題を解決するための手段〉 すなわち本発明は、P、 rett(leriのトリフ
トファナーゼ生産を司る遺伝子を含有する組換え体DN
Aを有する形質転換体、およびその形質転換体の培養物
、菌体またはその処理物をピルビン酸またはL−セリン
に作用させて、L−トリプトファンを生成蓄積せしめ、
反応液がらLトリプトファンを採取することを特徴とす
るしトリ11−ファンの製造法を提供するものである。
Means for Solving the Problems> That is, the present invention provides a recombinant DN containing a gene governing the production of tryptophanase of P, ret(leri).
A transformant having A, and a culture, bacterial cells, or a treated product of the transformant are allowed to act on pyruvate or L-serine to produce and accumulate L-tryptophan,
The present invention provides a method for producing tri-11-phane, which is characterized by collecting L-tryptophan from the reaction solution.

以下本発明に関し、遂次詳細に説明する。The present invention will be explained in detail below.

ベクターとして使用するプラスミドはp、 rettg
eri由来のものを用いる。たとえばp、rettge
rATCC25932、ATCC,9919、ATCC
29944から抽出できるか、p、 rettgerA
TCC25932から抽出したプラスミドpYU300
によりP、rettgeri  ATCC21118を
形質転換して得られたP、 reHger i  A 
TCC21118(PYU300)(微工研菌寄第84
75号)からプラスミドpYU300を抽出し使用する
方が便利である。
The plasmids used as vectors are p, rettg
Use one derived from eri. For example p, rettge
rATCC25932, ATCC,9919, ATCC
Can it be extracted from 29944?p, rettgerA
Plasmid pYU300 extracted from TCC25932
P. reHgeri A obtained by transforming P. reHgeri ATCC21118 by
TCC21118 (PYU300) (Microtechnical Laboratory No. 84
It is more convenient to extract and use plasmid pYU300 from (No. 75).

トリフトファナーゼ生産を司る遺伝子の供与菌として、
プロピテンシア属の菌を用いることができ、たとえばP
、rettgeri  ATCC29944を用いるこ
とができるがこの株に限定されるものではない。染色体
DNAの抽出は、たとえば文献2などの通常の方法に従
って行なうことができる。この場合溶菌過程は30〜6
5℃、20〜60分で行なうと、I)NAの収量を高め
ることができるが、これに限定はされない6L−スレオ
ニン発酵生産を司る遺伝子のセルフクローニングは、た
とえば文献3の欠損相補を用いたショットガン(Sho
t gun)法で行なう。
As a donor of the gene responsible for triftphanase production,
Bacteria of the genus Propitensia can be used, for example P
, Rettgeri ATCC29944 can be used, but is not limited to this strain. Chromosomal DNA can be extracted according to a conventional method such as that described in Reference 2, for example. In this case, the lytic process is 30-6
Self-cloning of the gene governing 6L-threonine fermentation production can be carried out at 5° C. for 20 to 60 minutes to increase the yield of NA, but is not limited to this method. Shotgun (Sho)
This is done using the tgun) method.

宿主としてはP、 rettger iのトリフトファ
ナーゼ欠損性変異株を用いることができるが、大腸菌(
E、colt)のトリフトファナーゼ欠損性変異株を宿
主として用い、さらにP、 rettger iにより
形質転換をしたものであってもよい。
As a host, a tryptophanase-deficient mutant strain of P. rettger i can be used, but E. coli (
The host may be a tryptophanase-deficient mutant strain of E. colt, which is further transformed with P. rettger i.

染色体DNAの断片化やプラスミドのベクター化のため
の切断は、たとえば旧ndllのような制限酵素を用い
た通常の酵素反応で行なうことができる。DNAの断片
とベクターとの連結は、たとえばT4DNAリガーゼの
ような酵素を用いた通常のライゲーション反応で行なう
ことができ、また、宿主のコンピテント化と形質転換は
、たとえば文献4のような通常の方法が適用できる。形
質転換体のスクリーニングは宿主のトリフトファナーゼ
欠損性のマーカー・レスキュー (lIlarker 
rescue )を指標として行なえるか、ベクターの
薬剤耐性の選択圧をもかけると能率がよい。またベクタ
ーの制限末端は、たとえば文献5のようなアルカリフォ
スファターゼ処理をしておくと、ベクターの自己環化を
防げる。
Fragmentation of chromosomal DNA and cleavage of plasmids for vectorization can be carried out by conventional enzymatic reactions using restriction enzymes such as old ndll. The DNA fragment and the vector can be ligated by a conventional ligation reaction using an enzyme such as T4 DNA ligase, and the host can be made competent and transformed by a conventional ligation reaction as described in Reference 4. method can be applied. Screening of transformants was performed using markers for rescue of host tritifphanase deficiency (Ilarker
It is more efficient to use the vector's drug resistance as an indicator, or to apply selective pressure for drug resistance of the vector. Furthermore, if the restricted ends of the vector are treated with alkaline phosphatase as described in Reference 5, self-cyclization of the vector can be prevented.

得られた形質転換体から組換え体プラスミドをたとえば
文献6の方法で抽出し、この組換え体プラスミドを用い
てトリフトファナーゼ生産性を有するp、 rettg
er i株を形質転換する。形質転換体はプラスミドの
有する薬剤耐性もしくは高し−トリプトファン生産性を
指標として選抜する。宿トリプトファン生産に関しては
公知の方法(文献1)に従って行なうことができる。
A recombinant plasmid is extracted from the obtained transformant, for example, by the method described in Reference 6, and this recombinant plasmid is used to extract p, rettg, which has tritrophanase productivity.
Transform the eri strain. Transformants are selected using the drug resistance or high tryptophan productivity of the plasmid as an indicator. The production of tryptophan can be carried out according to a known method (Reference 1).

また、反応液中に生成蓄積したL−トリプトファンの分
離・精製は通常の方法が適用できる。
Furthermore, ordinary methods can be applied to separate and purify L-tryptophan produced and accumulated in the reaction solution.

本発明の形質転換体微生物を用いることにより、従来知
られているP、 rettgeri )リプトファナー
ゼ生産菌を用いる場合に比べ、L−トリプトファンの蓄
積濃度か高いばかりでなく、培養時間が短縮できる。
By using the transformant microorganism of the present invention, not only the accumulated concentration of L-tryptophan can be increased, but also the culture time can be shortened, compared to the case where the conventionally known P. rettgeri) liptophanase-producing bacteria are used.

以下、実施例を挙げて本発明をさらに具体的に説明する
Hereinafter, the present invention will be explained in more detail with reference to Examples.

実施例1 (1)プラスミドの抽出分離 P、rettaeri  ATCC21118(pYU
300)(微工研菌寄第8475号)をLB培地(トリ
プトン1%、酵母エキス0.5%、塩化ナトリウム1%
、pH7,5)ljt中37°C117時間好気培養し
た菌体を15■リゾチーム塩酸塩を含んだ3mlの0.
5MNaCj201 MF、DTA−50m14Tri
s−HCj!(pH8)に懸濁し、37℃、15分間イ
ンキュベートした後、凍結誘拐し次に25m1の0、I
HTris−HCj! (pH9) −1%5DS−0
,1M  NaCj!を加え60℃、20分インキュベ
ートし溶解した。溶菌液を30. O0OrpF、30
分間遠心して得た上清に10■/ml  RNaseA
の10μρを添加し、37℃、1時間インキュベートし
た後、フェノール抽出、エタノール沈澱により粗DNA
を得た。
Example 1 (1) Extraction and separation of plasmid P, rettaeri ATCC21118 (pYU
300) (Feikoken Bibori No. 8475) was added to LB medium (tryptone 1%, yeast extract 0.5%, sodium chloride 1%).
, pH 7.5) Cells cultured aerobically for 117 hours at 37°C in ljt were added to 3ml of 0.1ml containing 15ml lysozyme hydrochloride.
5MNaCj201 MF, DTA-50m14Tri
s-HCj! (pH 8) and incubated at 37°C for 15 minutes, followed by cryoabduction and then 25 ml of 0, I
HTris-HCj! (pH9) -1%5DS-0
,1M NaCj! was added and incubated at 60°C for 20 minutes to dissolve. 30. O0OrpF, 30
Add 10μ/ml RNaseA to the supernatant obtained by centrifugation for 1 minute.
After 1 hour of incubation at 37°C, crude DNA was extracted by phenol extraction and ethanol precipitation.
I got it.

これをバイオゲル・カラムクロマトクラフィーとセシウ
ムクロライド−エチジウムブロマイド密度勾配平衡遠心
にかけ、55μgのプラスミドDNA (pYU300
)を得な。
This was subjected to biogel column chromatography and cesium chloride-ethidium bromide density gradient equilibrium centrifugation, and 55 μg of plasmid DNA (pYU300
).

プラスミドpYU300の長さは4.2Kbで薬剤耐性
はTc、CmRであった。またpYU300の制限地図
は第1図に示すとおりである。
The length of plasmid pYU300 was 4.2 Kb, and the drug resistance was Tc and CmR. Further, the restriction map of pYU300 is as shown in FIG.

(2)染色体DNAの抽出 IIlのLB培地で培養したp、 rettaeriA
 TCC29944の菌体を第1項の方法で溶解した後
、Saito−Miuraの方法(文献2)を用いて4
■の染色体DNAを得た。
(2) Extraction of chromosomal DNA p. rettaeriA cultured in LB medium
After the cells of TCC29944 were lysed by the method described in Section 1, they were lysed using the method of Saito-Miura (Reference 2).
Chromosomal DNA of (2) was obtained.

(3)制限酵素によるDNAの消化と分画文献6の反応
条件下0.25μg/μ(の(2)で取得したDNAを
0.12 unit/ μj!の制限酵素旧ndl[I
で2時間分解した分解物(DNA量で125μg)を1
2m1の10−40%ショ糖密度勾配中遠心し0.5 
Inlずつ分画採取した。遠心は日立RPS40Tロー
ターを用い、20℃、25,0OOrl)1124時間
行なった。
(3) Digestion and fractionation of DNA with restriction enzymes The DNA obtained in step (2) of 0.25 μg/μ (0.25 μg/μ) was digested with 0.12 units/μj! of the restriction enzyme old ndl[I
The decomposition product (125 μg of DNA) that was digested for 2 hours was
Centrifuge in 2 ml of 10-40% sucrose density gradient 0.5
Inl fractions were collected. Centrifugation was performed using a Hitachi RPS40T rotor at 20° C. for 1124 hours (25.0 O Orl).

電気泳動で各両分のDNAの長さを測定し、2〜10K
bの両分をプラスミドに連結した。
Measure the length of each DNA segment by electrophoresis, and
Both parts of b were ligated to a plasmid.

制限酵素は宝酒造■製を用い、活性単位は付属説明書の
定義によった。
Restriction enzymes manufactured by Takara Shuzo ■ were used, and the activity units were as defined in the attached manual.

(4)ベクターDNAの調整 宝酒造■製のp BR322を、制限酵素](ncll
[で完全分解した後、文献5に従いアルカリフォスター
ゼ処理を施した。
(4) Preparation of vector DNA pBR322 manufactured by Takara Shuzo
[After complete decomposition, alkaline forsterase treatment was performed according to Reference 5.

(5)宿主の作製 5n+lのLB培地中で37゛C13時間培養した対数
期のE、col iM M 294を文献8に従い、T
Mff衝液中で1100u/mlのNTQを用いて変異
誘発した後、インドール生産性テストを指標として本株
のトリフトファナーゼ欠損性変異株を単離した。
(5) Preparation of host Logarithmic-phase E. coli M M 294 cultured in 5n+l LB medium for 37°C for 13 hours was transfected with T according to Reference 8.
After mutagenesis using 1100 u/ml NTQ in Mff buffer, a tritifphanase-deficient mutant of this strain was isolated using an indole productivity test as an indicator.

(6)DNAの連結と形質転換 (3)で得たDNA断片10μgと、(4)で得たPB
R322プラスミドベクターDNA10μgとを、文献
5の方法を基に05単位の74DNAリガーゼと共に1
00μにの6mMMgcj!2 6mMβ−メルカプト
エタノール−0,5mMATP−6mHTris−HC
j!(pH7,6)中で14℃−晩インキユベートした
後、この反応液の10μ!を(5)で作製したE、co
liの宿主を文献4の方法でコンピテント化した菌液2
00μβと混ぜ4℃、45分間、次いで42℃、90秒
間、そして4℃、1分間インキュベートした後、LB培
地を加えて1f111とし、37℃、1時間振どう培養
して形質転換を行なった。
(6) DNA ligation and transformation 10 μg of DNA fragment obtained in (3) and PB obtained in (4)
10 μg of R322 plasmid vector DNA was mixed with 05 units of 74 DNA ligase based on the method described in Reference 5.
6mM Mgcj in 00μ! 2 6mM β-mercaptoethanol-0,5mMATP-6mHTris-HC
j! After incubating overnight at 14°C in pH 7.6, 10 μl of this reaction solution was incubated overnight at 14°C. E,co prepared in (5)
Bacterial solution 2 in which the li host was made competent by the method described in Reference 4
After mixing with 00μβ and incubating at 4°C for 45 minutes, then at 42°C for 90 seconds, and at 4°C for 1 minute, LB medium was added to make 1f111, and the mixture was cultured with shaking at 37°C for 1 hour to perform transformation.

(7)スクリーニング 前項(6)で調整した形質転換体ミクスチャーの菌を3
0μg / mlのアンピシリンを含むL−トリプトフ
ァンを単一窒素源とした最小培地(02%グルコース、
0.2%KH,2PO4,0,7%に2 HPO4,0
,01%MgSO4・7H20,0,05%クエン酸ソ
ーダ、L−トリプトファンIg/J!上に撒き、37℃
での静置培養で形質転換体の選択培養を行なった。培養
3日目で生じたコロニーを再度クロラムフェニコールを
含む最小培地に移植して増殖能を再確認した後、文献6
の方法に従い、プラスミドを抽出し、旧ndl[の消化
物を電気泳動にかけた。プラスミド中のインサー)DN
Aの長さが3゜6KbであるPBR322の複合体プラ
スミドをみとめ、pUsO4と名づけな。pUsO4を
図2に示した。
(7) Screening The transformant mixture prepared in the previous section (6) was
Minimal medium (02% glucose,
0.2%KH,2PO4,0,7% 2HPO4,0
, 01% MgSO4.7H20, 0.05% Sodium citrate, L-tryptophan Ig/J! Sprinkle on top and heat to 37℃
The transformants were selectively cultured by static culture. Colonies generated on the third day of culture were transplanted again to a minimal medium containing chloramphenicol to reconfirm their proliferation ability, and then
The plasmid was extracted and the digested product of old ndl was subjected to electrophoresis according to the method of . inserter) DN in plasmid
Observe a complex plasmid of PBR322 with A length of 3°6 Kb and name it pUsO4. pUsO4 is shown in Figure 2.

(8)トリフトファナーゼ遺伝子のpYtJ300への
クローニング pUsO4を含んだE、coliから(1)の方法でp
UsO4を抽出し、pYU300とともに(4)の方法
で制限酵素層ndl[用い完全分解し、次いで(6)の
方法でDNAを連結し、コンピテント化したE、col
iの宿主を形質転換した。
(8) Cloning of tritifphanase gene into pYtJ300 From E. coli containing pUsO4, p
UsO4 was extracted and completely digested with pYU300 using restriction enzyme layer ndl [using method (4)], and then DNA was ligated with method (6) to make competent E, col.
i host was transformed.

(9)スクリーニング (8)で調整した形質転換体ミクスチャーの菌を7,5
μg / mlのクロラムフェニコールを含む(7)に
示したL−Trpを単一窒素源とした最小培地を用い(
7)と同様にスクリーニングを行なった。
(9) The transformant mixture prepared in screening (8) was added to 7,5
Using a minimal medium containing μg/ml chloramphenicol and using L-Trp as the sole nitrogen source shown in (7),
Screening was performed in the same manner as in 7).

スクリーニングから得られた菌株より、(7)と同様に
プラスミドを抽出し、旧ndl[消化物の電気泳動によ
る確認の結果、プラスミド中のインサートDNAの長さ
が3.6 K bであるpYU300の複合体プラスミ
ドを認め、pUS301と名づけな。なお、pUs30
1を図3に示した。
Plasmids were extracted from the strains obtained from the screening in the same manner as in (7), and the length of the insert DNA in the plasmid was 3.6 Kb, as confirmed by electrophoresis of the old ndl [digested product]. Recognize the complex plasmid and name it pUS301. In addition, pUs30
1 is shown in FIG.

(10)pUs301のP、rettgeri  AT
CC29944への形質転換 (9)で得たpUs301を含むE、colはり(1)
の方法でpUs301を抽出し、文献4の方法でコンピ
テント化したp、rettger;  ATCC299
44へ(6)と同様に形質転換した。
(10) P of pUs301, rettgeri AT
E, col beam (1) containing pUs301 obtained by transformation into CC29944 (9)
pUs301 was extracted by the method of p, rettger; ATCC299 was made competent by the method of reference 4.
44 in the same manner as (6).

(11)スクリーニング 前項(10)で調整した形質転換体ミクスチャ−の菌を
クロラムフェニコール5μg / ml ヲ含んだLB
寒天培地上に撒き、37℃での静置培養で形質転換体の
選択培養を行なった。
(11) Screening The transformant mixture prepared in the previous section (10) was added to LB containing 5 μg/ml of chloramphenicol.
The transformants were plated on an agar medium and statically cultured at 37°C to selectively culture the transformants.

培養1日後で生じたコロニーを再度クロラムフェニコー
ルを含んだLB培地で増殖能を再確認した後、プラスミ
ドを抽出し、旧nd狙消化物を電気泳動でplJs30
1の確認を行なった。
After reconfirming the growth ability of the colonies generated after 1 day of culture in LB medium containing chloramphenicol, the plasmid was extracted, and the old ND target digest was electrophoresed to determine plJs30.
1 was confirmed.

(12))リプトファナーゼ反応によるL−トリプトフ
ァンの生産 (培養)  P、rettgeri  ATCC299
44、P、rettoeri  ATCC29944<
pUS301)をLB10o+Iを含んだ試験管で37
°C124時振盪培養しな。
(12)) Production of L-tryptophan by liptophanase reaction (culture) P. rettgeri ATCC299
44, P, rettoeri ATCC29944<
pUS301) in a test tube containing LB10o+I.
Do not incubate with shaking at 124°C.

上記培養液を表1に示した100の1培地を入れたII
lエーレンマイヤーフラスコに入れ、30℃、16時間
回転振 盪培養した。
II containing the above culture solution with 100 1 medium shown in Table 1
The cells were placed in an Erlenmeyer flask and cultured with rotational shaking at 30°C for 16 hours.

表 L−)リアトファン ソルポールW2O0 +1!リベブトンS コーンステイープリカー イーストエキストラクト コ  ハ  り  酸 g 0g 0g 60+r  g g L−システィン し−アルギニン L−メチオニン し−プロリン H2PO4 Mg5Ol・フH2O 0,6z 0.6g o、3f 0.31 g イオン交換水で1克とする。table L-) Liatfan Solpol W2O0 +1! Ribebuton S cornstarch liquor yeast extract Coacid acid g 0g 0g 60+r g g L-cystine Shi-Arginine L-methionine shi-proline H2PO4 Mg5Ol・FH2O 0,6z 0.6g o, 3f 0.31 g Reconstitute with ion-exchanged water.

pH7,0<KOHを用いる) 培養後、低速遠心(100rp1分)で菌体以外の固型
物を除去した後、高速遠心(6000rp!110分)
で集菌した。
pH 7.0<KOH is used) After culturing, solid matter other than bacterial cells is removed by low-speed centrifugation (100 rpm for 1 minute), followed by high-speed centrifugation (6000 rpm for 110 minutes).
Bacteria were collected.

上記菌体に表2の反応用液を添加し、さらにイノシン1
4gを添加し、30°C24時間振盪した。
The reaction solution shown in Table 2 was added to the above bacterial cells, and inosine 1
4 g was added and shaken at 30°C for 24 hours.

表   2 表 ピルビン酸ナトリウム あるいはL−セリン酢酸アンモ
ニウム a2SO3 ビリドキサルリン酸 インドール(メタノール10mlで溶解)8.0g 8.0g o、1g 10■ 6.0g イオン交換水で110m1とする。
Table 2 Sodium pyruvate or L-serine ammonium acetate a2SO3 Indole pyridoxal phosphate (dissolved in 10 ml of methanol) 8.0 g 8.0 g o, 1 g 10 6.0 g Make up to 110 ml with ion-exchanged water.

pH8,8(KOHで調整) 反応後、NaOHでPHを10〜11に調整し、1〜2
時間撹拌後一定量にメスアップし、ロイコノストック・
メセンテロイデスATCC8042を用いたバイオアッ
セイ法により生成L−トリプトファン量を定量した。
pH 8.8 (adjusted with KOH) After reaction, adjust pH to 10-11 with NaOH, then adjust pH to 1-2
After stirring for a certain amount of time, increase the volume to a certain level and use Leuconostoc.
The amount of L-tryptophan produced was determined by a bioassay method using Mesenteroides ATCC8042.

その結果を表3に示す。The results are shown in Table 3.

表3に示したようにピルビン酸ナトリウム、L−セリン
のどちらを基質とした場合も非形質転換株に比べ、約3
倍のL−)リプトファン生成量を示した。
As shown in Table 3, when using either sodium pyruvate or L-serine as a substrate, compared to the non-transformed strain, the
The amount of L-)liptophan produced was doubled.

〈発明の効果〉 本発明によれば、トリフトファナーゼの生産性の向上し
た形質転換体を得取することが可能となり、L−トリプ
トファンの生産を著しく向上させることができる。
<Effects of the Invention> According to the present invention, it is possible to obtain a transformant with improved productivity of tryptophanase, and the production of L-tryptophan can be significantly improved.

参考文献 1 、 H,Nakazawa et at : FE
BS  Lett  25 432、介護日向:蛋白質
・核酸・酸素 11.446〜450 (1966) 3 、V、Hershfield  et  at :
 Proc、Natl、^cad、S  ci。
Reference 1, H. Nakazawa et at: FE
BS Lett 25 432, Care Hyuga: Proteins, Nucleic Acids, Oxygen 11.446-450 (1966) 3, V, Hershfield et at:
Proc, Natl, ^cad, Sci.

U、S、A、71. 1)3455〜3459  (1
974)4、重定勝哉:細胞工学2.616〜626 
(15 、 R,W、Davisら編:^dvance
d Bacter+al  Genetics、  A
 Manual  for GeneticEnqin
eering p738〜739  (1980)6 
、  H,C,Birnboin and  J、Do
ly  : Nucleic  Ac1d  Res 
 7  1513〜1523  (1979)7 、 
T、Maniatisら編: Mo1ecular C
loning、 A Laboratory Manu
al  p  86〜96  (1982,)Cold
 Spring Harbor  Laborator
y  、  New York8、石川辰夫編″微生物
遺伝子学実験法”I)86〜88 (1982)共立出
U, S, A, 71. 1) 3455-3459 (1
974) 4, Katsuya Shigesada: Cell Engineering 2.616-626
(15, edited by R, W, Davis et al.: ^dvance
d Bacter + al Genetics, A
Manual for GeneticEnqin
earing p738-739 (1980)6
, H.C., Birnboin and J.Do.
ly: Nucleic Ac1d Res
7 1513-1523 (1979) 7,
Edited by T., Maniatis et al.: Molecular C
loning, A Laboratory Manu
al p 86-96 (1982,) Cold
Spring Harbor Laboratory
y, New York 8, Tatsuo Ishikawa (ed.) “Experimental Methods of Microbial Genetics” I) 86-88 (1982) Kyoritsu Shuppan

【図面の簡単な説明】[Brief explanation of drawings]

第1図はプラスミドpYU300の制限地図を、第2図
はプラスミドpUsO4の制限地図を、第3図はプラス
ミドpUs301の制限地図を示す。
FIG. 1 shows the restriction map of plasmid pYU300, FIG. 2 shows the restriction map of plasmid pUsO4, and FIG. 3 shows the restriction map of plasmid pUs301.

Claims (3)

【特許請求の範囲】[Claims] (1)トリフトファナーゼ生産を司る遺伝子を含む組換
え体DNAを有するプロビデンシア属の菌の形質転換体
(1) A transformant of a fungus belonging to the genus Providencia, which has a recombinant DNA containing a gene governing tritifphanase production.
(2)トリフトファナーゼ生産を司る遺伝子がプロビデ
ンシア属の菌株由来である請求項(1)記載の形質転換
体。
(2) The transformant according to claim (1), wherein the gene controlling tritifphanase production is derived from a strain of the genus Providencia.
(3)請求項(1)記載の形質転換体の培養物、菌体ま
たはその処理物をピルビン酸またはL−セリンに作用さ
せてL−トリプトファンを生成蓄積せしめ、反応液から
L−トリプトファンを採取することを特徴とするL−ト
リプトファンの製造法。
(3) L-tryptophan is produced and accumulated by allowing the culture, bacterial cells, or treated product of the transformant according to claim (1) to act on pyruvate or L-serine, and L-tryptophan is collected from the reaction solution. A method for producing L-tryptophan, characterized in that:
JP1077874A 1989-03-28 1989-03-28 Transformant capable of producing tryptophanase and method for producing L-tryptophan Expired - Lifetime JP2754689B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1077874A JP2754689B2 (en) 1989-03-28 1989-03-28 Transformant capable of producing tryptophanase and method for producing L-tryptophan

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1077874A JP2754689B2 (en) 1989-03-28 1989-03-28 Transformant capable of producing tryptophanase and method for producing L-tryptophan

Publications (2)

Publication Number Publication Date
JPH02255082A true JPH02255082A (en) 1990-10-15
JP2754689B2 JP2754689B2 (en) 1998-05-20

Family

ID=13646207

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1077874A Expired - Lifetime JP2754689B2 (en) 1989-03-28 1989-03-28 Transformant capable of producing tryptophanase and method for producing L-tryptophan

Country Status (1)

Country Link
JP (1) JP2754689B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5900254A (en) * 1988-04-20 1999-05-04 Norian Corporation Carbonated hydroxyapatite compositions and uses

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6328393A (en) * 1986-07-21 1988-02-06 Res Assoc Util Of Light Oil Novel plasmid
JPS63209589A (en) * 1987-02-27 1988-08-31 Toyobo Co Ltd Recombinant plasmid containing nal (n-acylneuraminate aldolase) gene, bacterium belonging to genus provindencia transformed by said plasmid and production of nal
JPS63222682A (en) * 1987-03-10 1988-09-16 Ajinomoto Co Inc Production of beta-tyrosinase and beta-tyrosinase-producing microorganism
JPH02124092A (en) * 1988-11-04 1990-05-11 Fujisawa Pharmaceut Co Ltd Production of batroxobin by genetic recombination

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6328393A (en) * 1986-07-21 1988-02-06 Res Assoc Util Of Light Oil Novel plasmid
JPS63209589A (en) * 1987-02-27 1988-08-31 Toyobo Co Ltd Recombinant plasmid containing nal (n-acylneuraminate aldolase) gene, bacterium belonging to genus provindencia transformed by said plasmid and production of nal
JPS63222682A (en) * 1987-03-10 1988-09-16 Ajinomoto Co Inc Production of beta-tyrosinase and beta-tyrosinase-producing microorganism
JPH02124092A (en) * 1988-11-04 1990-05-11 Fujisawa Pharmaceut Co Ltd Production of batroxobin by genetic recombination

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5900254A (en) * 1988-04-20 1999-05-04 Norian Corporation Carbonated hydroxyapatite compositions and uses

Also Published As

Publication number Publication date
JP2754689B2 (en) 1998-05-20

Similar Documents

Publication Publication Date Title
JPH028714B2 (en)
HU195533B (en) Process for producing microorganisms modificated with genetical engineering for producing amilase
JPS6012995A (en) Production of l-threonine and l-isoleucine by fermentation
JPS6062982A (en) Recombinant dna, bacteria having said recombinant dna and production of l-threonine or l-isoleucine using said bacteria
CN113817762A (en) Recombinant escherichia coli for producing pentamethylene diamine and application thereof
JPS6291193A (en) Production of l-threonine and l-isoleucine
JPH02255082A (en) Transformant having tryptophanase productivity and production of l-tryptophan
JPS6368091A (en) Production of amino acid
JPS63102692A (en) Production of l-glutamic acid
US4061540A (en) Cholesterol oxidaze and process for preparing same
JPH0227980A (en) Novel microorganism and preparation of d-biotin with the same microorganism
Dijkhuizen et al. Genetic manipulation of the restricted facultative methylotroph Hyphomicrobium X by the R-plasmid-mediated introduction of the Escherichia coli pdh genes
JPS62232392A (en) Production of l-thereonine and l-isoleucine
US4259446A (en) Process for preparation of deoxyribonucleases
EP0170257B1 (en) Process for producing l-tryptophan
JPH0511960B2 (en)
JPS63157986A (en) Production of l-phenylalanine by gene recombination
JPS58134994A (en) Preparation of l-phenylalanine by fermentation
NZ229029A (en) Cloned tryptophan synthase gene and recombinant plasmid containing the same
JPS61195695A (en) Production of threonine or isoleucine
JPH055479B2 (en)
JPH0476678B2 (en)
JPS63237793A (en) Production of l-threonine
JPH0468909B2 (en)
JPH01289493A (en) Production of l-threonine